Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:
Medical Device

FDA Considers National Registry For Silicone Breast Implants

This article was originally published in The Gray Sheet

  • News

Executive Summary

Due to lower-than-expected follow-up rates for Allergan and Johnson & Johnson/Mentor’s silicone-gel-filled breast implant post-approval studies, FDA advisory panel members last week called for a national registry to better document long-term outcomes and complications.
Table

View full table

Advertisement

Related Content

Medtech Insight
Breast Implant Makers Can Use Registries To Fulfill Post-Market Surveillance Duties
Medtech Insight
Ideal Implant Aims For Saline Breast Implant With Natural-Tissue Feel
Medtech Insight
Ideal Implant Aims For Saline Breast Implant With Natural-Tissue Feel
Medtech Insight
Post-Market Safety Data On Silicone-Gel Breast Implants May Prompt Labeling Changes
Medtech Insight
Post-Market Safety Data On Silicone-Gel Breast Implants May Prompt Labeling Changes
Medtech Insight
FDA Launches Effort To Integrate Ortho Device Registries
Medtech Insight
FDA Announces Possible Link Between Breast Implants And Cancer

Topics

Advertisement
Tags:
Medical Device
UsernamePublicRestriction

Register

MT030495

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By